Skip to main content
Clinical Trials/NCT01207284
NCT01207284
Completed
Phase 1

Influence of Physical Therapy Intervention on the Foot and Ankle in Gait Biomechanics in Individuals With Diabetic Neuropathy: a Randomized Clinical Trial

University of Sao Paulo General Hospital1 site in 1 country55 target enrollmentAugust 2010

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Diabetic Neuropathy With Loss of Sensation
Sponsor
University of Sao Paulo General Hospital
Enrollment
55
Locations
1
Primary Endpoint
Peak pressure at lateral forefoot
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The hypothesis is that a physical therapy intervention for foot and ankle of diabetic neuropathic individuals would affect positively the way they walk, lowering the harmful forces that these segments receive, that are associated mainly with lower range of movement, muscle weakness and loss of sensation. The participants will be randomly assigned into control group (regular treatment prescribed by their medical group) or into treatment group, that will receive 12 weeks of physical therapy intervention, twice a week, for 45 minutes each session. This will aim for increasing foot and ankle range of movement, muscle strength and improving sensory inputs.

Detailed Description

In this study, were included subjects diagnosed with diabetic neuropathy, aged between 45 and 65 years old. We aimed to assess the effect of a physical therapy program on biomechanics of lower limbs during gait.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
June 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • diabetes mellitus type 1 or 2 diagnosed for at least seven years
  • body mass index ranging 18.5-29.9 kg/m2 (normal and overweight classifications)
  • diabetic polyneuropathy diagnosed by the medical care center: score higher than 2 out of 13 in the Michigan Neuropathy Screening Instrument (MNSI) questionnaire, indicating the presence of at least two diabetic polyneuropathy symptoms; score higher than 1 out of 10 for physical assessment of the MNSI instrument, but always including impaired vibration perception
  • ability to walk independently in the laboratory

Exclusion Criteria

  • ulceration not healed for at least 6 months
  • partial or total foot amputation
  • receiving any physiotherapy intervention or offloading devices
  • neurological or orthopedic impairments
  • major vascular complications
  • severe retinopathy
  • severe nephropathy

Outcomes

Primary Outcomes

Peak pressure at lateral forefoot

Time Frame: 12 weeks

Secondary Outcomes

  • Peak pressure(24 weeks)
  • Sagittal peak of extensor moment of ankle(24 weeks)
  • Sagittal peak of flexor moment of ankle(24 weeks)
  • Michigan Neuropathy Screening Instrument score for symptoms(24 weeks)
  • Michigan Neuropathy Screening Instrument score for physical assessment(24 weeks)
  • Time-to-peak pressure(24 weeks)
  • Pressure-time integral(24 weeks)
  • Mean velocity of center of pressure displacement(12 weeks)
  • Mean velocity of center or pressure displacement(24 weeks)
  • Sagittal range of motion of ankle(24 weeks)
  • Functional tests score(24 weeks)
  • Muscle function score(24 weeks)
  • Activities-Specific Balance Confidence Scale (ABC)(24 weeks)

Study Sites (1)

Loading locations...

Similar Trials